The role of the CD40 antigen on malignant B cells

Leuk Lymphoma. 1996 Jul;22(3-4):229-35. doi: 10.3109/10428199609051753.

Abstract

An increasing amount of literature has been published concerning the interaction of the CD40 antigen and its ligand with regard to normal B cell ontogeny. In this review, an overview of the CD40 antigen and the CD40 ligand is given, focussing on their possible role in B cell malignancies. Data on the expression of the CD40 antigen on various B cell malignancies (acute and chronic leukemias, non-Hodgkin's lymphoma and multiple myeloma) are presented. The recently developed novel culture "CD40 system" is described. This system is a powerful tool used to culture normal B cells, but also most malignant B cells. We demonstrate in addition a more prominent role of the human Fc receptor presenting murine fibroblasts in the "CD40 system", especially in relation to cultured plasma cells. Finally, some important applications of the "CD40 system" are also summarized.

Publication types

  • Review

MeSH terms

  • Animals
  • B-Lymphocytes / pathology*
  • CD40 Antigens / physiology*
  • Humans
  • Leukemia, B-Cell / pathology*
  • Lymphoma, B-Cell / pathology*
  • Multiple Myeloma / pathology*

Substances

  • CD40 Antigens